TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,136,342 | -60.0% | 1,690,950 | +19.0% | 0.00% | -57.1% |
| Q2 2023 | $35,306,831 | +100.7% | 1,421,370 | +21.5% | 0.01% | +75.0% |
| Q1 2023 | $17,589,310 | +22.3% | 1,169,502 | -3.8% | 0.00% | +33.3% |
| Q4 2022 | $14,380,087 | +57.5% | 1,215,561 | -21.2% | 0.00% | +50.0% |
| Q3 2022 | $9,128,000 | +124.9% | 1,541,921 | +61.5% | 0.00% | +100.0% |
| Q2 2022 | $4,058,000 | -68.0% | 954,679 | -28.3% | 0.00% | -66.7% |
| Q1 2022 | $12,671,000 | -40.2% | 1,332,402 | +19.5% | 0.00% | -25.0% |
| Q4 2021 | $21,186,000 | -42.4% | 1,115,066 | +0.8% | 0.00% | -50.0% |
| Q3 2021 | $36,804,000 | +34.0% | 1,105,875 | +56.2% | 0.01% | +33.3% |
| Q2 2021 | $27,462,000 | -57.1% | 707,981 | -46.7% | 0.01% | -62.5% |
| Q1 2021 | $64,076,000 | +0.4% | 1,329,380 | +8.4% | 0.02% | 0.0% |
| Q4 2020 | $63,798,000 | +86.7% | 1,226,427 | -4.0% | 0.02% | +60.0% |
| Q3 2020 | $34,173,000 | +55.9% | 1,277,025 | +13.5% | 0.01% | +42.9% |
| Q2 2020 | $21,923,000 | +95.5% | 1,125,399 | -1.3% | 0.01% | +75.0% |
| Q1 2020 | $11,216,000 | -17.2% | 1,139,875 | -6.6% | 0.00% | +33.3% |
| Q4 2019 | $13,548,000 | +128.3% | 1,220,522 | +15.5% | 0.00% | +50.0% |
| Q3 2019 | $5,934,000 | -26.5% | 1,056,753 | +13.2% | 0.00% | 0.0% |
| Q2 2019 | $8,075,000 | +6.8% | 933,502 | -0.8% | 0.00% | 0.0% |
| Q1 2019 | $7,562,000 | +141.8% | 940,656 | +23.4% | 0.00% | +100.0% |
| Q4 2018 | $3,127,000 | +47.6% | 762,585 | +101.6% | 0.00% | 0.0% |
| Q3 2018 | $2,119,000 | -55.6% | 378,311 | +4.2% | 0.00% | 0.0% |
| Q2 2018 | $4,776,000 | -18.8% | 363,181 | -12.3% | 0.00% | 0.0% |
| Q1 2018 | $5,880,000 | +130.0% | 414,128 | +32.8% | 0.00% | 0.0% |
| Q4 2017 | $2,557,000 | +894.9% | 311,793 | +1335.0% | 0.00% | – |
| Q3 2017 | $257,000 | -48.7% | 21,727 | -49.5% | 0.00% | – |
| Q1 2017 | $501,000 | +534.2% | 43,020 | +152.8% | 0.00% | – |
| Q4 2016 | $79,000 | -11.2% | 17,019 | +48.8% | 0.00% | – |
| Q3 2016 | $89,000 | -87.5% | 11,439 | -73.4% | 0.00% | – |
| Q2 2015 | $714,000 | +80.3% | 43,053 | +68.5% | 0.00% | – |
| Q1 2015 | $396,000 | +308.2% | 25,552 | +148.5% | 0.00% | – |
| Q2 2014 | $97,000 | -86.6% | 10,282 | -90.9% | 0.00% | – |
| Q2 2013 | $724,000 | – | 113,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |